Racecadotril - Bioproject

Drug Profile

Racecadotril - Bioproject

Alternative Names: Acetorphan; Hidrasec; Racemic acetorphan; Tiorfan; Tiorfast; Tiorfix

Latest Information Update: 29 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bioprojet
  • Developer Abbott Laboratories; Bago; Bioprojet; Ferrer; GlaxoSmithKline; Leti; Nordic Drugs; Takeda
  • Class Antidiarrhoeals; Antisecretories; Benzyl compounds; Esters; Small molecules; Sulfhydryl compounds; Sulfur amino acids
  • Mechanism of Action Neprilysin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Diarrhoea

Most Recent Events

  • 29 Mar 2018 Phase-III clinical trials in Diarrhoea (In adolescents, In children, In infants) in Russia (PO) (NCT03463512)
  • 22 Mar 2018 Abbot plans a phase III trial for acute Diarrhoea (In infants, In children) in Taiwan in April 2018 (NCT03473561)
  • 19 Mar 2018 Abbott plans a phase III trial for Diarrhoea (In infants, In children, In adolescents) in Russia in March 2018 (NCT03463512)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top